UK to Begin Offering Immunotherapy for Mesothelioma Patients - Mesothelioma.net Blog
7/18/2022 12:00:00 AM2 years 9 months ago
by Written by Terri Oppenheimer
by Written by Terri Oppenheimer
Almost two years after the U.S. Food and Drug Administration approved the combination of nivolumab plus ipilimumab as first-line treatment...
Published on July 18, 2022 Almost two years after the U.S. Food and Drug Administration approved the combination of nivolumab plus ipilimumab as first-line treatment for adult patients with unresec… [+2007 chars]
full article...